CureSight Kifaa Cha Matibabu Ya Macho Ya Uvivu na Kobi Kor

Muundo CureSight Kifaa Cha Matibabu Ya Macho Ya Uvivu na Kobi Kor ni mshindi mashuhuri wa tuzo ya kifahari ya 2022 Tuzo ya Chuma ya A' Design Award katika Kategoria ya Mashindano ya Usanifu wa Vifaa vya Matibabu na Vifaa vya Hospitali.

ChumaBidhaa ya Matibabu· 2022

CureSight Kifaa Cha Matibabu Ya Macho Ya Uvivu

na Kobi Kor

Mteja: Novasight

Mshindi wa Tuzo ya Chuma ya A' Design Award katika Kategoria ya Bidhaa ya Matibabu

22,237

Mshindi wa Tuzo Aliyethibitishwa

Thibitisha Hali ya Tuzo kwa #133911

Gundua Sasa Tembelea Tovuti Tazama kwenye A' Design Award Taarifa kwa Vyombo vya Habari Beji ya Tuzo

Rangi

Muundo

Kuhusu CureSight Kifaa Cha Matibabu Ya Macho Ya Uvivu

Mchakato wa usanifu wa CureSight ulilenga kuunda bidhaa na suluhisho la matibabu ambalo litafanya athari chanya ya kijamii na kusaidia wagonjwa, ambao wengi wao ni watoto, kuepuka usumbufu na aibu inayohusika katika matibabu ya jadi kwa kiraka cha jicho. Muundo pia unasisitiza kuwa mwonekano na mwonekano wa bidhaa ni muhimu katika kuwatia moyo na kuwawezesha watoto. Msukumo wa muundo wa mitindo ulitoka kwa vifaa vya teknolojia ambavyo watoto wanapenda kutumia na kucheza navyo. Muundo wa umbo hutoa mwonekano mzuri na wa kisasa kwa bidhaa ya kifaa cha matibabu.

Utambuzi

Kuhusu Tuzo ya Chuma ya A' Design Award

CureSight Kifaa Cha Matibabu Ya Macho Ya Uvivu ni mshindi wa Tuzo ya Chuma ya A' Design Award, utambuzi wenye heshima unaotolewa kwa miundo mizuri inayokidhi mahitaji ya kitaalamu na ya kiviwanda yanayotarajiwa kutoka kwa kazi zilizobuniwa vizuri. Washindi wa Chuma huonyesha ustadi mkubwa, utaalamu wa hali ya juu, uelewa wa kitaalamu na uwezo wa kibunifu wa waumbaji wao. CureSight Kifaa Cha Matibabu Ya Macho Ya Uvivu inatarajiwa kuwa kazi inayothaminiwa sana, kupendwa na kuenziwa, ambayo ni ya vitendo na bunifu. Muundo huu ulioshinda Tuzo ya Chuma ya A' Design Award unajumuisha mbinu bora za tasnia na una sifa za kiufundi zenye uwezo zilizounganishwa na ujuzi na kipaji. CureSight Kifaa Cha Matibabu Ya Macho Ya Uvivu inaheshimiwa kwa uangalifu wake na imebuniwa kutoa maboresho ya ubora wa maisha yanayosaidia kuufanya ulimwengu kuwa mahali bora zaidi.

Nyuma ya Muundo

Vifaa vya Habari

Mikopo, wanachama wa timu na maelezo ya kiufundi yaliyotolewa na mbuni.

Sifa za Kipekee: The curesight is a powerful solution with great potential to totally change the treatment of lazy eye condition, with the important advantage of treating the lazy eye from the comfort of home and by watching any tv or streaming video content.
This healthcare solution for lazy eye condition integrates high-end technologies for eye-tracking and ai software tools for smart analyzing of the lazy eye condition and providing personal custom treatment. The gold standard care for lazy eye is placing a patch over the strong eye, an old-fashioned solution that suffers from very low compliance.
Vipimo na Ufungashaji: product net dimensions
Height 230mm
Width 390mm
Depth 60mm
Lebo: amlyopia, lazy eye, medical device, product design, social impact, degital healthcare
Teknolojia ya Uzalishaji: The design activity started with a brainstorming meeting to learn more about the problem from the clinical and user needs aspects, and to outline the main big limitations of today's treatment methods.
We also discussed the ergonomics and usability needs to be able to provide the best treatment.
during the design process, we tested several design concepts both aesthetically and with physical mockups,
Production technologies include aluminum CNC machining and anodize plating, for the front bezel and plastic injection for the back cover and small covers.
Changamoto ya Ubunifu: The creative challenge was to dress the unique technology components with style and to provide a good user experience to the users, the specific usability needs to enable good treatment for various populations and make it an appealing and empowering treatment device, and lead to important social impact
Utafiti: Following an intense effort over the last 18 months, the company officially announced that the company successfully met the primary endpoint of the CureSight randomized, controlled pivotal trial of amblyopia treatment against the gold standard patching.
This is the first-ever pivotal study in which a digital device was shown to be non-inferior to eye patching for amblyopia treatment in children.
The study also exhibited 93% adherence to the curesight treatment, as well as a 93% likelihood of the parents choosing curesight over patching.
Msukumo: The inspiration for the curesight product started from a personal experience when one of my kids needed to treat the lazy eye condition with the eye patch solution, I learned from this experience about the discomfort of wearing the eye patch for a few hours every day and especially how embarrassing it is from the social point of view.
The inspiration for the styling design came from the tech gadgets that kids love to use and play with, to provide a slick and modern design to a medical device product type, the front aluminum bezel, and the back swallowtail gives the product a clean gadget look.
Muda wa Mradi: The project started in 2019 in Tel Aviv, and finished in late 2021, the project was exhibited at the CES in January 2020 in Las Vegas
Mtiririko wa Uendeshaji: The patient, most likely kids will have the fun be treated by the Curesight while watching any video content they love to watch without any degradation in quality and from the comfort of home.
Wanatimu: Kobi Kor
Tal Samet
Haki za Picha: All images
Photograph and Illustrations: Novasight and Kobi Kor